218 related articles for article (PubMed ID: 25346374)
1. Interactions of human MSC with head and neck squamous cell carcinoma cell line PCI-13 reduce markers of epithelia-mesenchymal transition.
Böhrnsen F; Fricke M; Sander C; Leha A; Schliephake H; Kramer FJ
Clin Oral Investig; 2015 Jun; 19(5):1121-8. PubMed ID: 25346374
[TBL] [Abstract][Full Text] [Related]
2. Influence of TGF-β1 on tumor transition in oral cancer cell and BMSC co-cultures.
Böhrnsen F; Godek F; Kiesel J; Kramer FJ; Brockmeyer P; Schliephake H
J Craniomaxillofac Surg; 2017 May; 45(5):731-740. PubMed ID: 28318921
[TBL] [Abstract][Full Text] [Related]
3. Influence of tumour necrosis factor alpha on epithelial-mesenchymal transition of oral cancer cells in co-culture with mesenchymal stromal cells.
Böhrnsen F; Holzenburg J; Godek F; Kauffmann P; Moser N; Schliephake H
Int J Oral Maxillofac Surg; 2020 Feb; 49(2):157-165. PubMed ID: 31345665
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-34a regulates epithelial-mesenchymal transition and cancer stem cell phenotype of head and neck squamous cell carcinoma in vitro.
Sun Z; Hu W; Xu J; Kaufmann AM; Albers AE
Int J Oncol; 2015 Oct; 47(4):1339-50. PubMed ID: 26323460
[TBL] [Abstract][Full Text] [Related]
5. Incomplete epithelial-mesenchymal transition in p16-positive squamous cell carcinoma cells correlates with β-catenin expression.
Umbreit C; Flanjak J; Weiss C; Erben P; Aderhold C; Faber A; Stern-Straeter J; Hoermann K; Schultz JD
Anticancer Res; 2014 Dec; 34(12):7061-9. PubMed ID: 25503133
[TBL] [Abstract][Full Text] [Related]
6. PDGF-AA mediates mesenchymal stromal cell chemotaxis to the head and neck squamous cell carcinoma tumor microenvironment.
Watts TL; Cui R; Szaniszlo P; Resto VA; Powell DW; Pinchuk IV
J Transl Med; 2016 Dec; 14(1):337. PubMed ID: 27931212
[TBL] [Abstract][Full Text] [Related]
7. The upregulated α-catulin expression was involved in head-neck squamous cell carcinogenesis by promoting proliferation, migration, invasion, and epithelial to mesenchymal transition.
Zhang Z; Yang XF; Huang KQ; Ren L; Zhao S; Gou WF; Shen DF; Sun HZ; Takano Y; Zheng HC
Tumour Biol; 2016 Feb; 37(2):1671-81. PubMed ID: 26311049
[TBL] [Abstract][Full Text] [Related]
8. Tumor associated macrophages induce epithelial to mesenchymal transition via the EGFR/ERK1/2 pathway in head and neck squamous cell carcinoma.
Gao L; Zhang W; Zhong WQ; Liu ZJ; Li HM; Yu ZL; Zhao YF
Oncol Rep; 2018 Nov; 40(5):2558-2572. PubMed ID: 30132555
[TBL] [Abstract][Full Text] [Related]
9. N-cadherin expression is involved in malignant behavior of head and neck cancer in relation to epithelial-mesenchymal transition.
Nguyen PT; Kudo Y; Yoshida M; Kamata N; Ogawa I; Takata T
Histol Histopathol; 2011 Feb; 26(2):147-56. PubMed ID: 21154228
[TBL] [Abstract][Full Text] [Related]
10. Human Mesenchymal Stromal Cells Do Not Cause Radioprotection of Head-and-Neck Squamous Cell Carcinoma.
Rühle A; Lies M; Strack M; Perez RL; Bieber B; Thomsen AR; Bronsert P; Huber PE; Hess J; Knopf A; Wuchter P; Grosu AL; Nicolay NH
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887032
[TBL] [Abstract][Full Text] [Related]
11. The bidirectional tumor--mesenchymal stromal cell interaction promotes the progression of head and neck cancer.
Kansy BA; Dißmann PA; Hemeda H; Bruderek K; Westerkamp AM; Jagalski V; Schuler P; Kansy K; Lang S; Dumitru CA; Brandau S
Stem Cell Res Ther; 2014 Aug; 5(4):95. PubMed ID: 25115189
[TBL] [Abstract][Full Text] [Related]
12. Immunoexpression of Epithelial Mesenchymal Transition Proteins E-Cadherin, β-Catenin, and N-Cadherin in Oral Squamous Cell Carcinoma.
Angadi PV; Patil PV; Angadi V; Mane D; Shekar S; Hallikerimath S; Kale AD; Kardesai SG
Int J Surg Pathol; 2016 Dec; 24(8):696-703. PubMed ID: 27312520
[TBL] [Abstract][Full Text] [Related]
13. Markers of epithelial to mesenchymal transition in association with survival in head and neck squamous cell carcinoma (HNSCC).
Pectasides E; Rampias T; Sasaki C; Perisanidis C; Kouloulias V; Burtness B; Zaramboukas T; Rimm D; Fountzilas G; Psyrri A
PLoS One; 2014; 9(4):e94273. PubMed ID: 24722213
[TBL] [Abstract][Full Text] [Related]
14. Adipose-Derived Mesenchymal Stem Cells do not Affect the Invasion and Migration Potential of Oral Squamous Carcinoma Cells.
Sinha S; Narjus-Sterba M; Tuomainen K; Kaur S; Seppänen-Kaijansinkko R; Salo T; Mannerström B; Al-Samadi A
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899628
[TBL] [Abstract][Full Text] [Related]
15. Roles of mesenchymal stromal cells in the head and neck cancer microenvironment.
de Miranda MC; Melo MIA; Cunha PDS; Gentilini J; Faria JAQA; Rodrigues MA; Gomes DA
Biomed Pharmacother; 2021 Dec; 144():112269. PubMed ID: 34794230
[TBL] [Abstract][Full Text] [Related]
16. Gremlin1 Delivered by Mesenchymal Stromal Cells Promoted Epithelial-Mesenchymal Transition in Human Esophageal Squamous Cell Carcinoma.
Hong D; Liu T; Huang W; Liao Y; Wang L; Zhang Z; Chen H; Zhang X; Xiang Q
Cell Physiol Biochem; 2018; 47(5):1785-1799. PubMed ID: 29953975
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA MYOSLID promotes invasion and metastasis by modulating the partial epithelial-mesenchymal transition program in head and neck squamous cell carcinoma.
Xiong HG; Li H; Xiao Y; Yang QC; Yang LL; Chen L; Bu LL; Zhang WF; Zhang JL; Sun ZJ
J Exp Clin Cancer Res; 2019 Jun; 38(1):278. PubMed ID: 31238980
[TBL] [Abstract][Full Text] [Related]
18. Kallikrein-related peptidase 6 regulates epithelial-to-mesenchymal transition and serves as prognostic biomarker for head and neck squamous cell carcinoma patients.
Schrader CH; Kolb M; Zaoui K; Flechtenmacher C; Grabe N; Weber KJ; Hielscher T; Plinkert PK; Hess J
Mol Cancer; 2015 May; 14():107. PubMed ID: 25990935
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers of epithelial-mesenchymal transition in squamous cell carcinoma.
Scanlon CS; Van Tubergen EA; Inglehart RC; D'Silva NJ
J Dent Res; 2013 Feb; 92(2):114-21. PubMed ID: 23128109
[TBL] [Abstract][Full Text] [Related]
20. microRNA-203 suppresses invasion and epithelial-mesenchymal transition induction via targeting NUAK1 in head and neck cancer.
Obayashi M; Yoshida M; Tsunematsu T; Ogawa I; Sasahira T; Kuniyasu H; Imoto I; Abiko Y; Xu D; Fukunaga S; Tahara H; Kudo Y; Nagao T; Takata T
Oncotarget; 2016 Feb; 7(7):8223-39. PubMed ID: 26882562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]